Because we have previously shown that LY2090314 can inhibit murine ovarian cancer-MOSEC cells growth [31], we also examined the endogenous ETS1 and MMP-9 protein levels in the same experimental tumors of LY2090314-treated mice. Here, MMP9 is linked to ovarian carcinoma.